ZOETIS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 171.4 USD | -0.57% |
|
-0.03% | -13.23% |
| May. 29 | Transcript : Zoetis Inc. Presents at Stifel Jaws & Paws Conference, May-29-2024 12:05 PM | |
| May. 23 | Declaration of Voting Results by Zoetis Inc | CI |
ETFs positioned on Zoetis Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.36% | 8 M€ | -.--% | ||
| 0.34% | 727 M€ | +8.16% | ||
| 0.33% | 75 M€ | +5.48% | - | |
| 0.33% | 1 M€ | +0.04% | ||
| 0.31% | 276 M€ | +11.40% | - | |
| 0.31% | 559 M€ | +14.30% | ||
| 0.31% | 1,848 M€ | +18.39% | - | |
| 0.30% | 264 M€ | -.--% | - | |
| 0.30% | 187 M€ | +10.70% | - | |
| 0.30% | 477 M€ | +12.03% | ||
| 0.29% | 26 M€ | +22.35% | - | |
| 0.26% | 50 M€ | +10.09% | ||
| 0.23% | 34 M€ | +11.64% | - | |
| 0.23% | 744 M€ | +8.36% | ||
| 0.23% | 8 M€ | +6.81% | - | |
| 0.22% | 1 M€ | -.--% | ||
| 0.22% | 2,517 M€ | +12.11% | - | |
| 0.22% | 6 M€ | +17.98% | - | |
| 0.22% | 655 M€ | -.--% | - | |
| 0.22% | 273 M€ | -.--% | ||
| 0.22% | 1,174 M€ | +23.54% | ||
| 0.21% | 121 M€ | +8.08% | - | |
| 0.21% | 284 M€ | -.--% | ||
| 0.21% | 206 M€ | -.--% | ||
| 0.21% | 36 M€ | +2.79% | - | |
| 0.21% | 23 M€ | -.--% | - |
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
172.4
USD
Average target price
211.2
USD
Spread / Average Target
+22.53%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -13.23% | 78.65B | |
| +20.74% | 8.77B | |
| +25.50% | 3.68B | |
| -2.50% | 3.21B | |
| +12.67% | 1.77B | |
| -25.16% | 1.24B | |
| -27.23% | 1.2B | |
| -18.50% | 1.05B | |
| -7.57% | 951M | |
| -2.72% | 901M |
- Stock Market
- Equities
- ZTS Stock
- Funds and ETFs Zoetis Inc.
